G, C., E, R., B, M., M, T., S, B., M, B., . . . M, M. (2026). 4,4'-DMAR in-vivo acute cardiotoxicity: Differences between (±)cis-4,4'-DMAR and its coadministration with the (±)trans-4,4'-DMAR isomer. Frontiers in cardiovascular medicine, 13, 1763456. https://doi.org/10.3389/fcvm.2026.1763456
Chicago Style (17th ed.) CitationG, Corli, et al. "4,4'-DMAR In-vivo Acute Cardiotoxicity: Differences Between (±)cis-4,4'-DMAR and Its Coadministration with the (±)trans-4,4'-DMAR Isomer." Frontiers in Cardiovascular Medicine 13 (2026): 1763456. https://doi.org/10.3389/fcvm.2026.1763456.
MLA (9th ed.) CitationG, Corli, et al. "4,4'-DMAR In-vivo Acute Cardiotoxicity: Differences Between (±)cis-4,4'-DMAR and Its Coadministration with the (±)trans-4,4'-DMAR Isomer." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1763456, https://doi.org/10.3389/fcvm.2026.1763456.